The scrip had closed at Rs 616.45 in the previous session. The stock quoted a 52-week low of Rs 397.3 and a high of Rs 654.75. The company quoted a market-cap of Rs 36120.19 crore on the BSE.
On BSE, 12,745 shares have changed hands on the counter so far. At its prevailing price, the stock traded at 18.08 times its trailing 12-month EPS of Rs 34.09 per share and 1.59 times its book value. The return on equity (ROE) stood at Rs 10.77.
Key Financials
For the quarter ended 31-Dec-2022, Aurobindo Pharma Ltd. reported consolidated sales of Rs 6499.78 crore, up 7.13 per cent from the same quarter a year ago. The company reported 18.76 per cent YoY de-growth in net profit at Rs 491.26 crore for the latest quarter.
Technical indicators
The relative strength index (RSI) of the stock stood at Tuesday. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold when it is below 30.
Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price